Get Your Personalized Supplement StackSupplement Stack Quiz

Ficus Carica Fruit/Leaf Extract

Also known as: Fig, common fig, edible fig, Fig fruit extract, fig leaf extract, Ficus carica

Overview

Ficus carica, commonly known as the fig, is a deciduous tree native to the Middle East and western Asia, widely cultivated globally. Both its fruit and leaves are utilized in traditional medicine and are being investigated as nutraceuticals, typically in the form of aqueous or alcoholic extracts. The plant is rich in bioactive compounds such as flavonoids, phenolic acids, triterpenoids, coumarins, and sterols, which contribute to its diverse pharmacological activities. Research indicates potential anti-inflammatory, antimicrobial, antidiabetic, and anticancer properties. While preclinical studies show promising results, high-quality human clinical trials are limited, suggesting a moderate level of research maturity. Traditional uses include managing diabetes, skin disorders, and infections, but robust scientific validation for these applications in humans is still emerging.

Benefits

Preclinical studies have demonstrated several potential benefits of Ficus carica extracts. Anti-inflammatory effects have been observed, with rat models showing reduced VEGF and angiogenesis, comparable to diclofenac. Antimicrobial activity has been noted against bacteria like *Enterobacter cloacae* in in vitro studies. Furthermore, anticancer potential has been suggested by in vitro research, where extracts induced apoptosis in liver cancer cells. Secondary effects observed in animal and in vitro models include antidiabetic properties (lowering blood glucose), antioxidant activity, and neuroprotective effects. However, human data, particularly for skin health conditions like atopic dermatitis, have shown mixed results, with some biochemical improvements (e.g., reduced LDH and ALP) but no clear clinical symptom relief. The strength of evidence for most benefits is strong in preclinical settings but weak in human clinical trials, which are often small and underpowered. No strong evidence supports population-specific benefits, and the time course of benefits in humans is largely uncharacterized.

How it works

Ficus carica extracts exert their effects through various biological pathways, primarily by modulating inflammation, oxidative stress, and cell cycle regulation. They interact with key signaling molecules such as NF-κB and VEGF, influencing inflammatory responses and angiogenesis. In cancer cells, extracts can induce cytotoxicity and apoptosis, potentially through the generation of reactive oxygen species (ROS) and disruption of mitochondrial function. The extracts may also influence metabolic processes, including glucose and lipid metabolism, and interact with molecular targets like AMPK, GSK-3β, PARP-1, ERK2, CREB, and AKT2. While these mechanisms are well-documented in preclinical studies, the exact absorption and bioavailability of the active compounds in humans are not well characterized, which can impact their systemic effects.

Side effects

Ficus carica, when consumed as food, is generally regarded as safe. However, the safety profile of concentrated extracts in supplemental doses is less clear due to limited human clinical data. No common (over 5%) or uncommon (1-5%) side effects have been reported in available studies. Rare side effects (less than 1%) are not specifically documented, though a theoretical risk of allergic reactions exists, particularly for individuals with known allergies to *Ficus* species. No significant adverse events have been reported in the few clinical trials conducted. Regarding drug interactions, there is a potential for additive effects with antidiabetic or anti-inflammatory medications due to the extract's proposed mechanisms, but no specific interactions have been formally documented. Contraindications include known allergy to *Ficus* species. Insufficient data are available to establish safety guidelines for special populations such as pregnant or lactating women, or pediatric use.

Dosage

The minimum effective dose for Ficus carica extracts has not been established in humans. Animal studies have utilized leaf extracts in the range of 75–110 µg for anti-angiogenic effects. Optimal dosage ranges for human use are currently unknown, as human trials have often used fig leaf tea with unclear preparation details, making standardization difficult. Consequently, a maximum safe dose has also not been established. There are no specific timing considerations for administration, nor are there form-specific recommendations, although both aqueous and methanolic extracts have shown activity in preclinical models. Absorption factors and required cofactors for optimal efficacy are not well-studied in humans.

FAQs

Is Ficus carica extract safe to use?

While generally safe as a food, the safety of concentrated extracts in supplement form is not fully established due to limited human research. A theoretical risk of allergic reactions exists for individuals sensitive to Ficus species.

How effective is Ficus carica extract for health conditions?

Preclinical studies show promise for anti-inflammatory, antimicrobial, and anticancer effects. However, human clinical evidence is limited and inconsistent, with no robust demonstration of clinical benefits for specific conditions.

What is the recommended dosage and timing for Ficus carica extract?

There is no established minimum effective dose, optimal dosage range, or specific timing recommendations for human use due to insufficient research. Consult a healthcare professional for guidance.

Can Ficus carica extract replace conventional treatments?

No. Despite some promising preclinical findings, Ficus carica extract is not a proven substitute for conventional medical therapies for diabetes, cancer, skin disorders, or any other health condition.

Research Sources

https://www.dovepress.com/physicochemistry-nutritional-and-therapeutic-potential-of-ficus-carica-peer-reviewed-fulltext-article-DDDT – This review article synthesizes the physicochemical properties, nutritional value, and therapeutic potential of Ficus carica. It highlights the plant's rich phytochemical profile and summarizes various in vitro and in vivo studies demonstrating its anti-inflammatory, antimicrobial, antidiabetic, and anticancer activities, emphasizing the need for more human clinical trials.
https://pmc.ncbi.nlm.nih.gov/articles/PMC11146627/ – This study investigates the anticancer potential of Ficus carica leaf and fruit extracts on Huh7it liver cancer cells. It reports a dose-dependent increase in apoptosis and necrosis, suggesting that the extracts could be promising agents for liver cancer therapy, though further in vivo validation is required.
https://www.naturalhealthresearch.org/wp-content/uploads/2023/01/Fig-Leaf-Tea-Improves-Symptom-Severity-in-Adults-with-Atopic-Dermatitis.pdf – This human clinical trial, though small, explored the effects of fig leaf tea on adults with atopic dermatitis. It found significant reductions in biochemical markers like LDH and ALP, but did not observe a corresponding improvement in subjective clinical symptoms, indicating limited clinical efficacy despite some biochemical changes.
https://herbmedpharmacol.com/PDF/jhp-14-133.pdf – This research focuses on the anti-angiogenic and anti-inflammatory effects of Ficus carica leaf extract. An animal study demonstrated that the extract significantly reduced angiogenesis and VEGF levels in a rat model, comparable to the effects of diclofenac, supporting its potential as an anti-inflammatory agent.
https://pubmed.ncbi.nlm.nih.gov/37995897/ – This publication explores the molecular mechanisms underlying the therapeutic effects of Ficus carica. It delves into how the plant's compounds interact with various signaling pathways and molecular targets, such as NF-κB, AMPK, and GSK-3β, to exert its anti-inflammatory, antioxidant, and metabolic regulatory actions.